These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 8921781

  • 1. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians.
    Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R.
    Circulation; 1996 Nov 15; 94(10):2410-6. PubMed ID: 8921781
    [Abstract] [Full Text] [Related]

  • 2. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene.
    Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, Psaty BM, Longstreth WT, Koepsell TD, Raghunathan TE, Reitsma PH.
    Circulation; 1997 Jul 15; 96(2):412-7. PubMed ID: 9244205
    [Abstract] [Full Text] [Related]

  • 3. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction.
    Girelli D, Friso S, Trabetti E, Olivieri O, Russo C, Pessotto R, Faccini G, Pignatti PF, Mazzucco A, Corrocher R.
    Blood; 1998 Jun 01; 91(11):4158-63. PubMed ID: 9596662
    [Abstract] [Full Text] [Related]

  • 4. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM.
    Thromb Haemost; 2000 Apr 01; 83(4):563-70. PubMed ID: 10780318
    [Abstract] [Full Text] [Related]

  • 5. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
    de Jong SC, Stehouwer CD, van den Berg M, Kostense PJ, Alders D, Jakobs C, Pals G, Rauwerda JA.
    Arterioscler Thromb Vasc Biol; 1999 May 01; 19(5):1316-24. PubMed ID: 10323785
    [Abstract] [Full Text] [Related]

  • 6. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.
    Jacques PF, Kalmbach R, Bagley PJ, Russo GT, Rogers G, Wilson PW, Rosenberg IH, Selhub J.
    J Nutr; 2002 Feb 01; 132(2):283-8. PubMed ID: 11823591
    [Abstract] [Full Text] [Related]

  • 7. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.
    Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R.
    Circulation; 1996 Jan 01; 93(1):7-9. PubMed ID: 8616944
    [Abstract] [Full Text] [Related]

  • 8. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
    Födinger M, Mannhalter C, Wölfl G, Pabinger I, Müller E, Schmid R, Hörl WH, Sunder-Plassmann G.
    Kidney Int; 1997 Aug 01; 52(2):517-23. PubMed ID: 9264011
    [Abstract] [Full Text] [Related]

  • 9. The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
    Verhoef P, Kok FJ, Kluijtmans LA, Blom HJ, Refsum H, Ueland PM, Kruyssen DA.
    Atherosclerosis; 1997 Jul 11; 132(1):105-13. PubMed ID: 9247365
    [Abstract] [Full Text] [Related]

  • 10. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
    Postiglione A, Milan G, Ruocco A, Gallotta G, Guiotto G, Di Minno G.
    Gerontology; 2001 Jul 11; 47(6):324-9. PubMed ID: 11721146
    [Abstract] [Full Text] [Related]

  • 11. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.
    Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R.
    Cancer Res; 1997 Mar 15; 57(6):1098-102. PubMed ID: 9067278
    [Abstract] [Full Text] [Related]

  • 12. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study.
    Schmitz C, Lindpaintner K, Verhoef P, Gaziano JM, Buring J.
    Circulation; 1996 Oct 15; 94(8):1812-4. PubMed ID: 8873653
    [Abstract] [Full Text] [Related]

  • 13. Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample.
    de Bree A, Verschuren WM, Bjørke-Monsen AL, van der Put NM, Heil SG, Trijbels FJ, Blom HJ.
    Am J Clin Nutr; 2003 Mar 15; 77(3):687-93. PubMed ID: 12600862
    [Abstract] [Full Text] [Related]

  • 14. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
    Födinger M, Wölfl G, Fischer G, Rasoul-Rockenschaub S, Schmid R, Hörl WH, Sunder-Plassmann G.
    Kidney Int; 1999 Mar 15; 55(3):1072-80. PubMed ID: 10027946
    [Abstract] [Full Text] [Related]

  • 15. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
    Chango A, Potier De Courcy G, Boisson F, Guilland JC, Barbé F, Perrin MO, Christidès JP, Rabhi K, Pfister M, Galan P, Hercberg S, Nicolas JP.
    Br J Nutr; 2000 Dec 15; 84(6):891-6. PubMed ID: 11177206
    [Abstract] [Full Text] [Related]

  • 16. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype.
    Moat SJ, Ashfield-Watt PA, Powers HJ, Newcombe RG, McDowell IF.
    Clin Chem; 2003 Feb 15; 49(2):295-302. PubMed ID: 12560354
    [Abstract] [Full Text] [Related]

  • 17. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J.
    Circulation; 1999 May 11; 99(18):2383-8. PubMed ID: 10318658
    [Abstract] [Full Text] [Related]

  • 18. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
    Hanson NQ, Aras O, Yang F, Tsai MY.
    Clin Chem; 2001 Apr 11; 47(4):661-6. PubMed ID: 11274015
    [Abstract] [Full Text] [Related]

  • 19. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese.
    Moriyama Y, Okamura T, Kajinami K, Iso H, Inazu A, Kawashiri M, Mizuno M, Takeda Y, Sakamoto Y, Kimura H, Suzuki H, Mabuchi H.
    Atherosclerosis; 2002 Oct 11; 164(2):321-8. PubMed ID: 12204804
    [Abstract] [Full Text] [Related]

  • 20. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages.
    Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers GH, Eskes TK.
    J Nutr; 1998 Aug 11; 128(8):1336-41. PubMed ID: 9687553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.